BNP Paribas Financial Markets
BCYC

BNP Paribas Financial Markets’s Bicycle Therapeutics BCYC Stock Holding History

BNP Paribas Financial Markets’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Hold
1,016
– – ﹤0.01% 5476
2026
Q1 		$4.71K Sell
1,016
-100
-9% -$571 ﹤0.01% 5318
2025
Q4 		$7.9K Buy
1,116
+305
+38% +$2.25K ﹤0.01% 5198
2025
Q3 		$6.28K Buy
811
+281
+53% +$2.12K ﹤0.01% 5075
2025
Q2 		$3.68K Sell
530
-681
-56% -$5.42K ﹤0.01% 4985
2025
Q1 		$10.3K Buy
1,211
+531
+78% +$6.26K ﹤0.01% 4710
2024
Q4 		$9.52K Sell
680
-118
-15% -$2.53K ﹤0.01% 4850
2024
Q3 		$18.1K Sell
798
-380
-32% -$8.77K ﹤0.01% 3755
2024
Q2 		$23.8K Sell
1,178
-7,656
-87% -$173K ﹤0.01% 3615
2024
Q1 		$220K Sell
8,834
-28,017
-76% -$595K ﹤0.01% 3221
2023
Q4 		$666K Buy
36,851
+36,503
+10,489% +$604K ﹤0.01% 2640
2023
Q3 		$6.99K Buy
348
+159
+84% +$3.64K ﹤0.01% 3651
2023
Q2 		$4.82K Sell
189
-7,090
-97% -$165K ﹤0.01% 3676
2023
Q1 		$155K Buy
7,279
+7,117
+4,393% +$178K ﹤0.01% 3225
2022
Q4 		$4.79K Buy
+162
New +$4.35K ﹤0.01% 3666
2022
Q3 		– Sell
-333
Closed -$5.59K – 4749
2022
Q2 		$5.59K Buy
+333
New +$7.02K ﹤0.01% 3812

Other funds holding BCYC

FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

BNP Paribas Financial Markets's BCYC Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 1,016 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #5476.

BNP Paribas Financial Markets first reported a position in BCYC in Q2 2022 and has held it in 16 quarters since. The position peaked at $666K in Q4 2023. 75 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • BNP Paribas Financial Markets held 1,016 shares of Bicycle Therapeutics worth $4.31K as of Q2 2026.
  • BNP Paribas Financial Markets left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5476 holding.
  • BNP Paribas Financial Markets first reported a position in Bicycle Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • BNP Paribas Financial Markets's Bicycle Therapeutics position peaked at $666K in Q4 2023.
  • 75 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.